Research Topics
| Monica GuevaraSummaryCountry: Spain Publications
| Collaborators
|
Detail Information
Publications
[Treatment of hepatorenal syndrome]M Guevara
Gastroenterol Hepatol 26:270-4. 2003
Hepatorenal syndromeMonica Guevara
Hospital Clinic Barcelona, Liver Unit, IDIBAPS, CIBERHED, Barcelona, Spain
Expert Opin Pharmacother 12:1405-17. 2011..In patients with HRS type 1, treatment with vasopressin and albumin is the treatment of choice; however, 50% of patients do not respond to this treatment...- Cerebral magnetic resonance imaging reveals marked abnormalities of brain tissue density in patients with cirrhosis without overt hepatic encephalopathyMonica Guevara
Liver Unit, Hospital Clinic, University of Barcelona, Barcelona, Spain
J Hepatol 55:564-73. 2011..We applied advanced magnetic resonance imaging and Voxed based Morphometry analysis to assess brain tissue density in patients with cirrhosis... - Risk factors for hepatic encephalopathy in patients with cirrhosis and refractory ascites: relevance of serum sodium concentrationMonica Guevara
Liver Unit Hospital Clínic, Universitat de Barcelona, Barcelona, Spain
Liver Int 30:1137-42. 2010..In conclusion, in patients with refractory ascites, the occurrence of HE is related to the impairment of liver and renal function and presence of hyponatraemia... - Hyponatremia is a risk factor of hepatic encephalopathy in patients with cirrhosis: a prospective study with time-dependent analysisMonica Guevara
Liver Unit, Hospital Clinic, University of Barcelona, Villarroel 170, Barcelona, Spain
Am J Gastroenterol 104:1382-9. 2009..The aim of this study was to investigate whether hyponatremia is a risk factor of overt hepatic encephalopathy (HE) in cirrhosis... - Hepatorenal syndromeMonica Guevara
Liver Unit, Hospital Clinic, Institut d Investigacions Biomèdiques August Pi Sunyer, University of Barcelona School of Medicine, Barcelona, Catalunya, Spain
Dig Dis 23:47-55. 2005.... - Hepatorenal syndromeMonica Guevara
Liver Unit, Hospital Clinic, Institut d Investigacions Biomediques August Pi i Sunyer IDIBAPS, University of Barcelona, C Villarroel 173, 08032 Barcelona, Spain
Int J Biochem Cell Biol 37:22-6. 2005..They also appear to improve survival and may serve as a bridge to liver transplantation, which is the treatment of choice in these patients... - Effects of contrast media on renal function in patients with cirrhosis: a prospective studyMonica Guevara
Liver Unit, Hospital Clinic, Barcelona, Spain
Hepatology 40:646-51. 2004..Cirrhosis does not appear to be a risk factor for the development of contrast media-induced nephrotoxicity... - [Transjugular intrahepatic portosystemic shunt and refractory ascites]M Guevara
, Institut de Malalties Digestives, , Barcelona,
Gastroenterol Hepatol 27:285-91. 2004 - [Treatment of ascites and the hepatorenal syndrome]Monica Guevara
Hospital Clinic de Barcelona, IDIBAPS, Universidad de Barcelona, Villarroel 170 08036 Barcelona, Espana
Acta Gastroenterol Latinoam 34:27-35. 2004 - Hyponatremia in cirrhosis: clinical features and managementMarta Martín-Llahí
Liver Unit, Hospital Clinic, IDIBAPS, University of Barcelona, Spain
Gastroenterol Clin Biol 30:1144-51. 2006..In addition, the possible beneficial effects of these drugs in the prevention of hepatic encephalopathy would be worth studying... - Prognostic importance of the cause of renal failure in patients with cirrhosisMarta Martín-Llahí
Liver Unit, Hospital Clinic, University of Barcelona, Barcelona, Spain
Gastroenterology 140:488-496.e4. 2011..The prognostic value of the different causes of renal failure in cirrhosis is not well established. This study investigated the predictive value of the cause of renal failure in cirrhosis... - Hyponatremia impairs early posttransplantation outcome in patients with cirrhosis undergoing liver transplantationMaria Carlota Londoño
Liver Unit, Hospital Clinic, Universitat de Barcelona, Barcelona, Spain
Gastroenterology 130:1135-43. 2006..We aimed to assess the effects of hyponatremia at the time of transplantation on posttransplantation outcome in patients with cirrhosis... - Renal failure and hyponatremia in patients with cirrhosis and skin and soft tissue infection. A retrospective studyGustavo Pereira
University of Barcelona, Barcelona, Spain
J Hepatol 56:1040-6. 2012..This study aimed at assessing the characteristics, occurrence of renal failure, and outcome of cirrhotic patients with skin and soft tissue infection... - Urinary neutrophil gelatinase-associated lipocalin as biomarker in the differential diagnosis of impairment of kidney function in cirrhosisClaudia Fagundes
Liver Unit, Hospital Clinic, University of Barcelona, Barcelona, Catalunya, Spain
J Hepatol 57:267-73. 2012..We aimed at assessing the usefulness of neutrophil gelatinase-associated lipocalin (NGAL), a biomarker of tubular damage, in the differential diagnosis of impairment of kidney function in cirrhosis... - [Hyponatremia in liver cirrhosis: pathogenesis and treatment]Monica Guevara
Servei d Hepatologia, Hospital Clinic de Barcelona, Universitat de Barcelona, Institut d Investigacions Biomèdiques August Pi Sunyer, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Barcelona, Spain
Endocrinol Nutr 57:15-21. 2010..Since hypervolemic hyponatremia is by far the most frequent form of this disorder, the present chapter will concentrate specifically on hypervolemic hyponatremia in cirrhosis... - Effects of treatment of hepatorenal syndrome before transplantation on posttransplantation outcome. A case-control studyTea Restuccia
Liver Unit, Institute for Digestive Diseases, Hospital Clinic, University of Barcelona, Villarroel 170, Barcelona 08036, Catalunya, Spain
J Hepatol 40:140-6. 2004..Pretransplant renal function is the major determinant of survival after liver transplantation (LTx). Patients with hepatorenal syndrome (HRS) have a poor outcome after LTx compared with patients transplanted without HRS... 
MELD score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantationMaria Carlota Londoño
Liver Unit, Hospital Clinic, Universitat de Barcelona, Institut de Investigacions Biomèdiques August Pi Sunyer, CIBER de Enfermedades Hepáticas y Digestivas and Centro de Investigaciones Biomédicas Esther Koplowitz, Barcelona, Spain
Gut 56:1283-90. 2007....- Hyponatremia in patients treated with terlipressin for severe gastrointestinal bleeding due to portal hypertensionElsa Solá
Liver Unit, Hospital Clinic, University of Barcelona, Barcelona, Catalunya, Spain
Hepatology 52:1783-90. 2010..It develops rapidly after start of therapy, may be severe in some patients and is associated with neurological complications, and is usually reversible after terlipressin withdrawal... - Predictors of response to therapy with terlipressin and albumin in patients with cirrhosis and type 1 hepatorenal syndromeAndré Nazar
Liver Unit, Hospital Clinic, University of Barcelona, Barcelona, Catalunya, Spain
Hepatology 51:219-26. 2010..Alternative treatment strategies to terlipressin and albumin should be investigated for patients with type 1 HRS and low likelihood of response to vasoconstrictor therapy... - Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized studyMarta Martín-Llahí
Liver Unit, Hospital Clinic, University of Barcelona School of Medicine, Institut d Investigacions Biomédiques August Pi Sunyer IDIBAPS, Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas CIBERehd, Barcelona, Spain
Gastroenterology 134:1352-9. 2008..Hepatorenal syndrome is common in patients with advanced cirrhosis and constitutes a major problem in liver transplantation. There is no effective medical treatment for hepatorenal syndrome... - Albumin for bacterial infections other than spontaneous bacterial peritonitis in cirrhosis. A randomized, controlled studyMonica Guevara
Liver Unit, Hospital Clinic, University of Barcelona, Barcelona, Catalunya, Spain
J Hepatol 57:759-65. 2012..Whether albumin has similar beneficial effects in patients with infections other than SBP is unknown... - Tolvaptan, an oral vasopressin antagonist, in the treatment of hyponatremia in cirrhosisAndres Cardenas
GI Unit, Institut de Malalties Digestives i Metaboliques, Hospital Clinic, University of Barcelona, Barcelona, Catalunya, Spain
J Hepatol 56:571-8. 2012..Specific data on the safety and efficacy of tolvaptan in patients with cirrhosis and hyponatremia has not been exclusively evaluated... - Aquaporin-1 and aquaporin-2 urinary excretion in cirrhosis: Relationship with ascites and hepatorenal syndromeChristina Esteva-Font
Molecular Biology Laboratory, , Barcelona, Spain
Hepatology 44:1555-63. 2006..Finally, aquaporin-1 does not appear to play a role in the progressive dysregulation of extracellular fluid volume in cirrhosis... - Factors related to quality of life in patients with cirrhosis and ascites: Relevance of serum sodium concentration and leg edemaElsa Solá
Liver Unit, Hospital Clinic, University of Barcelona, Barcelona, Catalunya, Spain Institut d Investigacions Biomèdiques August Pi Sunyer IDIBAPS, Spain Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBERehd, Spain Instituto Reina Sofia de Investigación Nefrológica, Spain
J Hepatol 57:1199-206. 2012..We aimed at assessing the relationship between serum sodium concentration and other clinical and analytical parameters on HRQL in cirrhosis with ascites... - Acute kidney injury is an early predictor of mortality for patients with alcoholic hepatitisJose Altamirano
Liver Unit, Hospital Clinic, University of Barcelona, Barcelona, Spain
Clin Gastroenterol Hepatol 10:65-71.e3. 2012..We studied effects of acute kidney injury (AKI) on survival of patients with AH... - Hepatorenal syndromePere Gines
Liver Unit, Hospital Cli nic, Institut d Investigacions Biomèdiques August Pi Sunyer, University of Barcelona School of Medicine, Barcelona, Catalunya, Spain
Lancet 362:1819-27. 2003..Although these findings need to be confirmed, these two strategies represent innovative approaches to lower the frequency of HRS in clinical practice... - LEFT ventricular function assessed by echocardiography in cirrhosis: Relationship to systemic hemodynamics and renal dysfunctionAndré Nazar
Liver Unit, Hospital Clinic, University of Barcelona, Barcelona, Catalunya, Spain Institut d Investigacions Biomèdiques August Pi Sunyer IDIBAPS, Spain Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBERehd, Spain Instituto Reina Sofía de Investigación Nefrológica IRSIN, Spain
J Hepatol 58:51-7. 2013..The current study aimed at assessing the potential role of cardiac abnormalities in the pathogenesis of circulatory and renal dysfunction in cirrhosis... - Hyponatremia in cirrhosis: pathogenesis, clinical significance, and managementPere Gines
Liver Unit, Hospital Clinic, University of Barcelona, Institut d Investigacions Biomèdiques August Pi Sunyer, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas IDIBAPS, Barcelona, Catalunya, Spain
Hepatology 48:1002-10. 2008..Treatment with vaptans represents a novel approach to improving serum sodium concentration in cirrhosis... - Recent advances in hepatorenal syndromeVicente Arroyo
Liver Unit, Hospital Clinic, Institut d Investigacions Biomèdiques August Pi Sunyer, University of Barcelona School of Medicine, Barcelona, Catalunya, Spain
Trop Gastroenterol 26:13-20. 2005..Nevertheless, liver transplantation should still be done in suitable patients even after improvement of renal function because the outcome of HRS is poor...